Observatory · observe first
Regeneron Pharmaceuticals
REGN · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.
Historical time machine
Historical observation
20182026
Universe weight
0.197%
12M weight contribution
+0.000 pp
3M weight contribution
-0.002 pp
12M price return
-5.9%
Share of matched S&P 500 members
Monthly observations through Jun 2018
Company price index
A separate dimension from market allocation
Historical observations
Most recent 24 observations at or before the selected month
| Month | Market cap | Universe weight | 12M weight change | 12M return | Above 6M weight average |
|---|---|---|---|---|---|
| Jun 2018 | $32.4bn | 0.197% | +0.000 pp | -5.9% | Yes |
| May 2018 | $28.2bn | 0.171% | -0.025 pp | -18.1% | No |
| Apr 2018 | $28.5bn | 0.175% | -0.021 pp | -17.2% | No |
| Mar 2018 | $32.4bn | 0.199% | +0.002 pp | -6.1% | Yes |
| Feb 2018 | $30.1bn | 0.180% | -0.016 pp | -12.6% | No |
| Jan 2018 | $34.4bn | 0.196% | +0.000 pp | +0.0% | No |
Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.